Results 1 to 1 of 1

Thread: HairMax Achieves New Milestones in Hair Growth with Statistically Significant Clinica

  1. #1
    Join Date
    Apr 2008

    Default HairMax Achieves New Milestones in Hair Growth with Statistically Significant Clinica

    This Press Release on the results of the recent clinical studies on the efficacy of the HairMax in males and FDA Clearance for 3 new models was just released and below are the details.

    April 21, 2011, Boca Raton, FL – Lexington International, LLC is pleased to announce that it has successfully completed 2 clinical studies of the HairMax LaserComb proving the efficacy and safety of 3 new devices for the treatment of androgenetic alopecia (hereditary hair loss). The analysis showed that 95.4% of participants using the HairMax LaserComb experienced hair growth. Furthermore, the average increases in hair count for participants in the HairMax LaserComb group was 20.4 hairs per centimeter square, which is considered medically and scientifically significant. None of the participants in the studies experienced any serious side effects. Based in part on submission of clinical results, the FDA Granted Class II Clearance 510(k) K103368 of these medical devices for sale in the USA for the ‘Treatment of Hair Loss and Promotion of Hair Growth’ in males.

    The two double-blind, device-controlled multi-center studies were conducted by Zoe Draelos, MD, David Goldberg, MD, Michael Jarrett, MD, and Abe Mercadis, MD, under GCP (Good Clinical Practice) guidelines and IRB (Institutional Review Board) approval. These clinical trials are posted on Submission of these data was a major component of the FDA filing and was a key factor in the agency’s decision to clear the HairMax LaserComb. The FDA 510(k) Clearance further validates the HairMax as a non-drug option for treating hereditary hair loss in males.

    The FDA indication of use for the new models is as follows:

    “The HairMax LaserComb® is indicated to treat androgenetic alopecia, and promote hair growth in males who have Norwood Hamilton Classifications of IIa to V patterns of hair loss and Fitzpatrick Skin Types I to IV.”

    Since 2001, Lexington has completed a total of seven clinical studies with 460 subjects and all of the studies have demonstrated the efficacy and safety of the HairMax LaserComb. These statistically significant clinical study results validate the fact that the HairMax should be considered as a first line treatment for appropriate people suffering from hereditary hair loss.

    The three new models now available are the HairMax Advanced 7 (7 lasers), the HairMax Lux 9 (9 lasers), and the HairMax Professional 12 (12 lasers). The number of lasers contained in each model determines the treatment time required during each session. The availability of these three new models, at different price points, offers the benefits of this exciting treatment to a larger audience, including retail. The New HairMax models feature a sleek, modern design and are now battery powered. Users no longer have to be tethered to a wall outlet, offering complete freedom of movement when using the device.


    Visit the website:
    Follow us:
    Access the HairMax Blog:
    Online ordering of the HairMax LaserComb:
    Last edited by LAS; 04-20-2011 at 01:36 PM.

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts